Wu L L, Cox A, Roe C J, Dziadek M, Cooper M E, Gilbert R E
Department of Medicine, Austin and Repatriation Medical Centre, Victoria, Australia.
Kidney Int. 1997 May;51(5):1553-67. doi: 10.1038/ki.1997.214.
Transforming growth factor-beta (TGF-beta) and the renin-angiotensin system (RAS) have both been implicated in the pathogenesis of chronic renal disease. The present experiment investigated the chronology of TGF-beta 1 gene expression following subtotal nephrectomy (STNx) in the rat and the effect of blocking the RAS by angiotensin converting enzyme (ACE) inhibition or by angiotensin II receptor (AT1) antagonism. Rats that had undergone subtotal nephrectomy developed hypertension, proteinuria, renal impairement, glomerulosclerosis, tubulointerstitial fibrosis and mononuclear cell infiltration. These changes were associated with a 2.5-fold increase in TGF-beta 1 gene expression during a 16-week time course. In situ hybridization localized TGF-beta 1 mRNA to sclerotic glomeruli, areas of tubuloin-terstitial injury and sites of mononuclear cell infiltration. Administration of the ACE inhibitor ramipril and the AT1 receptor blocker valsartan blunted the increase in TGF-beta 1 mRNA, and attenuated the structural and functional manifestations of injury. These data suggest an interaction between the intrarenal RAS and TGF-beta in the pathogenesis of the glomerular and tubulointerstitial fibrosis that follow a major reduction in renal mass.
转化生长因子-β(TGF-β)和肾素-血管紧张素系统(RAS)均与慢性肾病的发病机制有关。本实验研究了大鼠肾大部切除(STNx)后TGF-β1基因表达的时间进程,以及通过抑制血管紧张素转换酶(ACE)或拮抗血管紧张素II受体(AT1)阻断RAS的作用。接受肾大部切除的大鼠出现了高血压、蛋白尿、肾功能损害、肾小球硬化、肾小管间质纤维化和单核细胞浸润。这些变化与16周时间内TGF-β1基因表达增加2.5倍有关。原位杂交将TGF-β1 mRNA定位于硬化的肾小球、肾小管间质损伤区域和单核细胞浸润部位。给予ACE抑制剂雷米普利和AT1受体阻滞剂缬沙坦可抑制TGF-β1 mRNA的增加,并减轻损伤的结构和功能表现。这些数据表明,在肾质量大幅减少后发生的肾小球和肾小管间质纤维化的发病机制中,肾内RAS和TGF-β之间存在相互作用。